- Home
- ELBM vs TLPH Comparison
ELBM vs TLPH Comparison
Compare ELBM & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELBM | TLPH |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 70.3M |
| IPO Year | 2022 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ELBM | TLPH |
|---|---|---|
| Price | $0.51 | $1.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.15 | N/A |
| AVG Volume (30 Days) | ★ 314.8K | 104.9K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.71 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.49 | $0.69 |
| 52 Week High | $8.70 | $1.57 |
Technical Indicators
Market Signals| Indicator | ELBM | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 37.94 | 45.04 |
| Support Level | $0.50 | $1.17 |
| Resistance Level | $0.60 | $1.29 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 1.13 | 27.27 |
Price Performance
Historical ComparisonAbout ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry. The Company's operating segments are Refinery, Exploration and Evaluation, Corporate and Other.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.